iNOS inhibitors (AstraZeneca)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameiNOS inhibitors (AstraZeneca)
Drug Alias NameAR-C102222AR-C85016AR-C102222ADAR-C17708ARAR-C95971 +[6] 
ClassificationSmall molecules
Mechanisms of ActionNitric oxide synthase, inducible inhibitors
TargetsNitric oxide synthase, inducible
Therapy Area/IndicationsPainInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsPainInflammation

Other Information

ATC CodeN/A
Related LinksN/A